January 17, 2025

CDC Urges 24-Hour Bird Flu Tests

The CDC emphasizes timely testing for avian influenza A in hospitalized patients to prevent delays and enhance rapid public health responses. Low person-to-person transmission risk has been reported with ongoing U.S. cases among farmworkers.

Reuters

January 16, 2025

FDA Clears First Nicotine Pouches for U.S. Market

FDA grants first-ever marketing authorization for ZYN nicotine pouches following a scientific review that showed lower health risks compared to traditional tobacco products and minimal youth usage.

Conexiant

January 16, 2025

FDA Clears Phase 2 Trial: Lorundrostat for OSA-Hypertension

Mineralys Therapeutics receives FDA clearance for a phase II clinical trial investigating lorundrostat, an aldosterone synthase inhibitor, in patients with moderate-to-severe obstructive sleep apnea and hypertension.

Conexiant

January 15, 2025

FDA to Revoke Red No. 3

Red No. 3 is found in many popular food items, including Pop Tarts, Dole Fruit Packs, Double Bubble Gum, Peeps, and more.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 15, 2025

FDA Proposes Nicotine Limits for Tobacco

The US Food and Drug Administration has introduced a proposal to cap nicotine levels in cigarettes, with the goal of curbing addiction, reducing smoking rates, and averting millions of tobacco-related deaths by 2100.

Conexiant

January 09, 2025

CDC Expands Adult Pneumococcal Vaccine Age Range

CDC recommends pneumococcal vaccines for adults 50+, expanding previous age-based guidance.

Conexiant

January 09, 2025

Medicare Covers Tirzepatide for Sleep Apnea

Eli Lilly's tirzepatide gets Medicare coverage for sleep apnea, widening access to weight-loss treatment. Are obesity drugs getting a breakthrough?

Reuters

January 07, 2025

RSV Vaccines Add Guillain-Barré Warning

FDA flags increased GBS risk with GSK and Pfizer's respiratory syncytial virus vaccines, Arexvy and Abrysvo.

Reuters